New Journal Website is available at:

Published by: Kowsar

Targeting Advanced Glycation End Products in Cardiac Surgery: The Unexplored Alternative

Antonio Nenna 1 , Francesco Nappi 2 , Massimo Chello 1 and Cristiano Spadaccio 3 , *
Authors Information
1 Department of Cardiovascular Surgery, Universita Campus Bio-Medico di Roma, Rome, Italy
2 Department of Cardiac Surgery, Centre Cardiologique du Nord de Saint-Denis, Paris, France
3 Department of Cardiothoracic Surgery, Golden Jubilee National Hospital, Clydebank, Glasgow, UK
Article information
  • Research in Cardiovascular Medicine: May 2016, 5 (2); e31707
  • Published Online: March 5, 2016
  • Article Type: Letter
  • Received: July 22, 2015
  • Accepted: August 18, 2015
  • DOI: 10.5812/cardiovascmed.31707

To Cite: Nenna A, Nappi F, Chello M, Spadaccio C. Targeting Advanced Glycation End Products in Cardiac Surgery: The Unexplored Alternative, Res Cardiovasc Med. 2016 ;5(2):e31707. doi: 10.5812/cardiovascmed.31707.

Copyright: Copyright © 2016, Research in Cardiovascular Medicine. .
  • 1. Nenna A, Nappi F, Avtaar Singh SS, Sutherland FW, Di Domenico F, Chello M, et al. Pharmacologic Approaches Against Advanced Glycation End Products (AGEs) in Diabetic Cardiovascular Disease. Res Cardiovasc Med. 2015; 4(2)[DOI][PubMed]
  • 2. Bari Investigators. . The final 10-year follow-up results from the BARI randomized trial. J Am Coll Cardiol. 2007; 49(15): 1600-6[DOI][PubMed]
  • 3. Creagh-Brown BC, Quinlan GJ, Hector LR, Evans TW, Burke-Gaffney A. Association between preoperative plasma sRAGE levels and recovery from cardiac surgery. Mediators Inflamm. 2013; 2013: 496031[DOI][PubMed]
  • 4. Simm A, Wagner J, Gursinsky T, Nass N, Friedrich I, Schinzel R, et al. Advanced glycation endproducts: a biomarker for age as an outcome predictor after cardiac surgery? Exp Gerontol. 2007; 42(7): 668-75[DOI][PubMed]
  • 5. Liu X, Chen Q, Shi S, Shi Z, Lin R, Tan L, et al. Plasma sRAGE enables prediction of acute lung injury after cardiac surgery in children. Crit Care. 2012; 16(3)[DOI][PubMed]
  • 6. Agostoni P, Banfi C, Brioschi M, Magri D, Sciomer S, Berna G, et al. Surfactant protein B and RAGE increases in the plasma during cardiopulmonary bypass: a pilot study. Eur Respir J. 2011; 37(4): 841-7[DOI][PubMed]
  • 7. Uchida T, Ohno N, Asahara M, Yamada Y, Yamaguchi O, Tomita M, et al. Soluble isoform of the receptor for advanced glycation end products as a biomarker for postoperative respiratory failure after cardiac surgery. PLoS One. 2013; 8(7)[DOI][PubMed]
  • 8. Basta G, Corciu AI, Vianello A, Del Turco S, Foffa I, Navarra T, et al. Circulating soluble receptor for advanced glycation end-product levels are decreased in patients with calcific aortic valve stenosis. Atherosclerosis. 2010; 210(2): 614-8[DOI][PubMed]
  • 9. Campbell DJ, Somaratne JB, Jenkins AJ, Prior DL, Yii M, Kenny JF, et al. Diastolic dysfunction of aging is independent of myocardial structure but associated with plasma advanced glycation end-product levels. PLoS One. 2012; 7(11)[DOI][PubMed]
  • 10. Zakliczynski M, Nozynski J, Konecka-Mrowka D, Pyka L, Trybunia D, Nikiel B, et al. Different role of advanced glycation end products in pathology of transplanted heart in patients with or without diabetes mellitus type 2. Transplant Proc. 2009; 41(8): 3185-9[DOI][PubMed]
  • 11. Yamagishi S, Fukami K, Matsui T. Evaluation of tissue accumulation levels of advanced glycation end products by skin autofluorescence: A novel marker of vascular complications in high-risk patients for cardiovascular disease. Int J Cardiol. 2015; 185: 263-8[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader